I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hoisnard, Léa
13
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-022-24050-7. , 2022
Link:
https://hal.u-pec.fr/hal..
?
2
Three-Year Outcomes in Kidney Transplant Recipients Switche..:
Morel, Antoine
;
Hoisnard, Léa
;
Dudreuilh, Caroline
...
info:eu-repo/semantics/altIdentifier/doi/10.3389/ti.2022.10228. , 2022
Link:
https://hal.u-pec.fr/hal..
?
3
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-022-24050-7. , 2022
Link:
https://hal.u-pec.fr/hal..
?
4
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-022-24050-7. , 2022
Link:
https://hal.u-pec.fr/hal..
?
5
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-022-24050-7. , 2022
Link:
https://hal.u-pec.fr/hal..
?
6
Three-Year Outcomes in Kidney Transplant Recipients Switche..:
Morel, Antoine
;
Hoisnard, Léa
;
Dudreuilh, Caroline
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043102/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
7
Three-Year Outcomes in Kidney Transplant Recipients Switche..:
Morel, Antoine
;
Hoisnard, Léa
;
Dudreuilh, Caroline
...
info:eu-repo/semantics/altIdentifier/doi/10.3389/ti.2022.10228. , 2022
Link:
https://hal.u-pec.fr/hal..
?
8
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666557/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
9
Adverse events associated with JAK inhibitors in 126,815 re..:
Hoisnard, Léa
;
Lebrun-Vignes, Bénédicte
;
Maury, Sébastien
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065106/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
10
Long-term persistence of second-line biologics in psoriatic..:
Pina Vegas, Laura
;
Hoisnard, Léa
;
Bastard, Léa
..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730400/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Adverse events associated with JAK inhibitors in 126,815 re..:
Léa Hoisnard
;
Bénédicte Lebrun-Vignes
;
Sébastien Maury
...
https://doi.org/10.1038/s41598-022-10777-w. , 2022
Link:
https://doi.org/10.1038/..
?
12
Long-term persistence of second-line biologics in psoriatic..:
Pascal Claudepierre
;
Léa Bastard
;
Lea Hoisnard
..
https://rmdopen.bmj.com/content/8/2/e002681.full. , 2022
Link:
https://doi.org/10.1136/..
?
13
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Hugo Jourdain
;
Léa Hoisnard
;
Emilie Sbidian
.
https://doi.org/10.1038/s41598-022-24050-7. , 2022
Link:
https://doi.org/10.1038/..
1-13
